Update in Staging Systems
Aside from purely taxonomic purposes, the staging of prostatic cancer is important to planning mangement, estimating prognosis, characterizing individual patients or groups of patients, and comparing results of various treatments. There is as yet no universally accepted clinical staging classification for prostatic cancer but two systems, the American and the TNM, with various modifications, are widely used (Whitmore 1984).
KeywordsProstatic Cancer Seminal Vesicle Pelvic Lymph Node Digital Rectal Examination Pelvic Lymphadenectomy
Unable to display preview. Download preview PDF.
- American Joint Committee for Cancer Staging and End Results Reporting (1978) Manual for staging of cancer. Whiting Press, New Jersey, pp 119–124Google Scholar
- Beahrs OH, Myers MH (eds) (1983) Manual for staging of cancer. JB Lippincott, Philadelphia, pp 159–163Google Scholar
- Boxer RJ (1977) Adenocarcinoma of the prostate gland. Urol Survey 27: 75–82Google Scholar
- Catalona WJ (1984) Prostate cancer. Grune & Stratton, Orlando, pp 57-83 Catalona WJ, Scott WW (1978) Carcinoma of the prostate: a review. J Urol 119: 1–8Google Scholar
- deVere White R, Paulson DF, Glenn JF (1977) The clinical spectrum of prostate cancer. J Urol 117: 323–327Google Scholar
- Rich AR (1935) On the frequency of occurrence of occult carcinoma of the prostate. J Urol 33: 215–223Google Scholar
- Veterans Administration Cooperative Urological Research Group (1967) Treatment and survival of patients with cancer of the prostate. Surg Gynecol Obstet 124: 1011–1017Google Scholar